RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

Why is it management bashing to suggest a stock can rise in spite of, rather that due to managment's strategy, or lack thereof.
I think you're right to assume that there's the possibility that SA results will go the way of the FDA letter, and Tran.
The stock may still rise despite the lack of transparency re: SA.
A thinly traded stock in our neck of the woods can be driven up or down on small amounts of money.
Let's all hope we can be manipulated upwards
without the need for "management to the rescue" hyperbole,
or even substantial progress on high impact platforms
since that may be years off.
The real test will be getting over the warrant overhang in the high twenties.
IMHO.